187 related articles for article (PubMed ID: 19265258)
1. Potential differentiation of tumor bearing mouse CD11b+Gr-1+ immature myeloid cells into both suppressor macrophages and immunostimulatory dendritic cells.
Narita Y; Wakita D; Ohkur T; Chamoto K; Nishimura T
Biomed Res; 2009 Feb; 30(1):7-15. PubMed ID: 19265258
[TBL] [Abstract][Full Text] [Related]
2. Analysis of splenic Gr-1int immature myeloid cells in tumor-bearing mice.
Yamamoto Y; Ishigaki H; Ishida H; Itoh Y; Noda Y; Ogasawara K
Microbiol Immunol; 2008 Jan; 52(1):47-53. PubMed ID: 18352913
[TBL] [Abstract][Full Text] [Related]
3. Anti-IL-6 receptor mAb eliminates myeloid-derived suppressor cells and inhibits tumor growth by enhancing T-cell responses.
Sumida K; Wakita D; Narita Y; Masuko K; Terada S; Watanabe K; Satoh T; Kitamura H; Nishimura T
Eur J Immunol; 2012 Aug; 42(8):2060-72. PubMed ID: 22653638
[TBL] [Abstract][Full Text] [Related]
4. Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF.
Dolcetti L; Peranzoni E; Ugel S; Marigo I; Fernandez Gomez A; Mesa C; Geilich M; Winkels G; Traggiai E; Casati A; Grassi F; Bronte V
Eur J Immunol; 2010 Jan; 40(1):22-35. PubMed ID: 19941314
[TBL] [Abstract][Full Text] [Related]
5. Modulating the expression of IFN regulatory factor 8 alters the protumorigenic behavior of CD11b+Gr-1+ myeloid cells.
Stewart TJ; Liewehr DJ; Steinberg SM; Greeneltch KM; Abrams SI
J Immunol; 2009 Jul; 183(1):117-28. PubMed ID: 19542426
[TBL] [Abstract][Full Text] [Related]
6. Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development.
Greifenberg V; Ribechini E; Rössner S; Lutz MB
Eur J Immunol; 2009 Oct; 39(10):2865-76. PubMed ID: 19637228
[TBL] [Abstract][Full Text] [Related]
7. Role of immature myeloid Gr-1+ cells in the development of antitumor immunity.
Li Q; Pan PY; Gu P; Xu D; Chen SH
Cancer Res; 2004 Feb; 64(3):1130-9. PubMed ID: 14871848
[TBL] [Abstract][Full Text] [Related]
8. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
Ferret-Bernard S; Saï P; Bach JM
Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293
[TBL] [Abstract][Full Text] [Related]
9. IFN-γ regulates survival and function of tumor-induced CD11b+ Gr-1high myeloid derived suppressor cells by modulating the anti-apoptotic molecule Bcl2a1.
Medina-Echeverz J; Haile LA; Zhao F; Gamrekelashvili J; Ma C; Métais JY; Dunbar CE; Kapoor V; Manns MP; Korangy F; Greten TF
Eur J Immunol; 2014 Aug; 44(8):2457-67. PubMed ID: 24810636
[TBL] [Abstract][Full Text] [Related]
10. Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species.
Kusmartsev S; Nefedova Y; Yoder D; Gabrilovich DI
J Immunol; 2004 Jan; 172(2):989-99. PubMed ID: 14707072
[TBL] [Abstract][Full Text] [Related]
11. Macrophage-derived dendritic cells have strong Th1-polarizing potential mediated by beta-chemokines rather than IL-12.
Zou W; Borvak J; Marches F; Wei S; Galanaud P; Emilie D; Curiel TJ
J Immunol; 2000 Oct; 165(8):4388-96. PubMed ID: 11035076
[TBL] [Abstract][Full Text] [Related]
12. Antigen-specific immunity and cross-priming by epithelial ovarian carcinoma-induced CD11b(+)Gr-1(+) cells.
Tomihara K; Guo M; Shin T; Sun X; Ludwig SM; Brumlik MJ; Zhang B; Curiel TJ; Shin T
J Immunol; 2010 Jun; 184(11):6151-60. PubMed ID: 20427766
[TBL] [Abstract][Full Text] [Related]
13. Interferon regulatory factor-8 modulates the development of tumour-induced CD11b+Gr-1+ myeloid cells.
Stewart TJ; Greeneltch KM; Reid JE; Liewehr DJ; Steinberg SM; Liu K; Abrams SI
J Cell Mol Med; 2009 Sep; 13(9B):3939-50. PubMed ID: 20196788
[TBL] [Abstract][Full Text] [Related]
14. Gr-1intCD11b+ myeloid-derived suppressor cells accumulate in corneal allograft and improve corneal allograft survival.
Choi W; Ji YW; Ham HY; Yeo A; Noh H; Jin SE; Song JS; Kim HC; Kim EK; Lee HK
J Leukoc Biol; 2016 Dec; 100(6):1453-1463. PubMed ID: 27370015
[TBL] [Abstract][Full Text] [Related]
15. CD11b+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis.
Zhu B; Bando Y; Xiao S; Yang K; Anderson AC; Kuchroo VK; Khoury SJ
J Immunol; 2007 Oct; 179(8):5228-37. PubMed ID: 17911608
[TBL] [Abstract][Full Text] [Related]
16. Lack of Muc1-regulated beta-catenin stability results in aberrant expansion of CD11b+Gr1+ myeloid-derived suppressor cells from the bone marrow.
Poh TW; Bradley JM; Mukherjee P; Gendler SJ
Cancer Res; 2009 Apr; 69(8):3554-62. PubMed ID: 19351842
[TBL] [Abstract][Full Text] [Related]
17. CD11b+Gr-1
Sendo S; Saegusa J; Okano T; Takahashi S; Akashi K; Morinobu A
Arthritis Rheumatol; 2017 Dec; 69(12):2314-2327. PubMed ID: 28805019
[TBL] [Abstract][Full Text] [Related]
18. Tumor-induced CD11b(+) Gr-1(+) myeloid-derived suppressor cells exacerbate immune-mediated hepatitis in mice in a CD40-dependent manner.
Kapanadze T; Medina-Echeverz J; Gamrekelashvili J; Weiss JM; Wiltrout RH; Kapoor V; Hawk N; Terabe M; Berzofsky JA; Manns MP; Wang E; Marincola FM; Korangy F; Greten TF
Eur J Immunol; 2015 Apr; 45(4):1148-58. PubMed ID: 25616156
[TBL] [Abstract][Full Text] [Related]
19. GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells.
Morales JK; Kmieciak M; Knutson KL; Bear HD; Manjili MH
Breast Cancer Res Treat; 2010 Aug; 123(1):39-49. PubMed ID: 19898981
[TBL] [Abstract][Full Text] [Related]
20. Differently immunogenic cancers in mice induce immature myeloid cells that suppress CTL in vitro but not in vivo following transfer.
Schmidt K; Zilio S; Schmollinger JC; Bronte V; Blankenstein T; Willimsky G
Blood; 2013 Mar; 121(10):1740-8. PubMed ID: 23305737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]